# To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen

> **NCT01081639** · PHASE3 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 34 (actual)

## Conditions studied

- Infertility
- Ovulation Induction

## Interventions

- **DRUG:** Follitropin alfa liquid formulation
- **DRUG:** Follitropin beta liquid formulation

## Key facts

- **NCT ID:** NCT01081639
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2004-09
- **Final completion:** 2004-09
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2014-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01081639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01081639, "To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT01081639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*